Kyle A Farina - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of Pharmacy Practice|July 5, 2019

Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the LiteratureKyle A Farina, Michael P Kane

JAAPA : Official Journal of the American Academy of Physician Assistants|December 21, 2023

Acute myeloid leukemia: Current understanding and managementMichelle Becker, Kyle A Farina, John Mascarenhas

JCO Precision Oncology|January 31, 2024

Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic InsightsShivani Handa, Kyle A Farina, Michelle Becker, et al.

JACC. Advances|June 18, 2026

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of Pharmacy Practice|July 5, 2019

Programmed Cell Death-1 Monoclonal Antibody Therapy and Type 1 Diabetes Mellitus: A Review of the LiteratureKyle A Farina, Michael P Kane

JAAPA : Official Journal of the American Academy of Physician Assistants|December 21, 2023

Acute myeloid leukemia: Current understanding and managementMichelle Becker, Kyle A Farina, John Mascarenhas

JCO Precision Oncology|January 31, 2024

Discontinuation Syndrome With JAK2 Selective Agents: Case Presentation and Mechanistic InsightsShivani Handa, Kyle A Farina, Michelle Becker, et al.

JACC. Advances|June 18, 2026

Cardiovascular Events in Patients With Acute Myeloid Leukemia Treated With Venetoclax: A Multicenter Cohort StudySabin Filimon, Azin Ghamari, Azin Vakilpour, et al.

Pageof 1